Pomelo enhances cyclosporine bioavailability in healthy male thai volunteers

Journal of Clinical Pharmacology

Volumn 55, Issue 4, 2015, Pages 377-383

  Anlamlert, Wirin ^a   Sermsappasuk, Pakawadee ^a   Yokubol, Dhirayudh ^a   Jones, Sirada ^a  

^a NARESUAN UNIVERSITY   (Thailand)

Author keywords

bioavailability; Citrus grandis; cyclosporine; drug interaction; pomelo

Indexed keywords

CYCLOSPORIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD; BLOOD SAMPLING; BODY MASS; CLINICAL PROTOCOL; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; EUROPEAN MEDICINES AGENCY; FEMALE; GOOD CLINICAL PRACTICE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PUMMELO; THERAPEUTIC EQUIVALENCE; ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOAVAILABILITY; CITRUS; CONTROLLED STUDY; FRUIT; HERB DRUG INTERACTION; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL AVAILABILITY; CITRUS; CROSS-OVER STUDIES; CYCLOSPORINE; FRUIT; HEALTHY VOLUNTEERS; HERB-DRUG INTERACTIONS; HUMANS; MALE; YOUNG ADULT;

EID: 84924416006     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.430     Document Type: Article

References (40)

1. Klintmalm G, Sawe J, Ringden O, von Bahr C, Magnusson A,. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection. Transplantation. 1985; 39 (2): 132-137.
2. Porter GA, Bennett WM, Sheps SG,. Cyclosporine-associated hypertension. National High Blood Pressure Education Program. Arch Intern Med. 1990; 150 (2): 280-283.
3. Hauben M,. Cyclosporine neurotoxicity. Pharmacotherapy. 1996; 16 (4): 576-583.
4. Llaudõ I, Colom H, Giménez-Bonafé P, et al. Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study. Transpl Int. 2013; 26 (2): 177-186.
5. Tornatore KM, Brazeau D, Dole K, et al. Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients. J Clin Pharmacol. 2013; 53 (10): 1039-1047.
6. Haddad A, Davis M, Lagman R,. The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions. Support Care Cancer. 2007; 15 (3): 251-257.
7. Zhou SF, Lim LY, Chowbay B,. Herbal modulation of P-glycoprotein. Drug Metab. Rev. 2004; 36 (1): 57-104.
8. Dahan A, Altman H,. Food-drug interaction: grapefruit juice augments drug bioavailability:mechanism, extent and relevance. Eur J Clin Nutr. 2004; 58 (1): 1-9.
9. Sermsappasuk P, Chaiyakunapruk N, Lohitnavy M, Kitiyakara C,. Assessing clinical evidence of drug interactions between citrus juices and cyclosporine. Asian Biomed. 2013; 7 (4): 477-489.
10. Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6',7'-dihydroxybergamottin in grapefruit juice and seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and p-glycoprotein. Clin Pharmacol Ther. 1999; 65: 237-244.
11. Lee M, Min DI, Ku YM, Flanigan M,. Effect of grapefruit juice on pharmacokinetics of microemulsion cyclosporine in African American subjects compared with Caucasian subjects: does ethnic difference matter. J Clin Pharmacol. 2001; 41 (3): 317-323.
12. Ku YM, Min DI, Flanigan M,. Effect of grapefruit juice on the pharmacokinetics of microemulsion cyclosporine and its metabolite in healthy volunteers: does the formulation difference matter? J Clin Pharmacol. 1998; 38 (10): 959-965.
13. Yee GC, Stanley DL, Pessa LJ, et al. Effect of grapefruit juice on blood cyclosporin concentration. Lancet. 1995; 345 (8955): 955-956.
14. Ducharme MP, Warbasse LH, Edwards DJ,. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther. 1995; 57 (5): 485-491.
15. Brunner LJ, Munar MY, Vallian J, et al. Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients. Pharmacotherapy. 1998; 18 (1): 23-29.
16. Proppe DG, Hoch OD, McLean AJ, Visser KE,. Influence of chronic ingestion of grapefruit juice on steady-state blood concentrations of cyclosporine A in renal transplant patients with stable raft function. Br J Clin Pharmacol. 1995; 39 (3): 337-338.
17. Brunner LJ, Pai KS, Munar MY, Lande MB, Olyaei AJ, Mowry JA,. Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients. Pediatr Transplant. 2000; 4 (4): 313-321.
18. Herlitz H, Edgar B, Hedner T, Lidman K, Karlberg I,. Grapefruit juice: a possible source of variability in blood concentration of cyclosporin A. Nephrol Dial Transplant. 1993; 8 (4): 375.
19. Nowack R,. Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort-and beyond! Nephrology (Carlton, Vic.). 2008; 13 (4): 337-347.
20. Guo L-Q, Fukuda K, Ohta T, Yamazoe Y,. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos. 2000; 28 (7): 766-771.
21. Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest. 1997; 15 (10): 2545-2553.
22. Sorkhi H, Oliaei F, Moghadamnia AA, Pouramin M, Firoozjahi AR,. Effect of orange and tangerine juice on cyclosporine levels in renal transplant recipients. Transplant Proc. 2007; 39 (4): 1228-1230.
23. Schwarz UI, Johnston PE, Bailey DG, Kim RB, Mayo G, Milstone A,. Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. Br J Clin Pharmacol. 2005; 62 (4): 485-491.
24. Ohnishi A, Matsuo H, Yamada S, et al. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4. Br J Pharmacol. 2000; 130 (6): 1369-1377.
25. Egashira K, Fukuda E, Onga T, et al. Pomelo-induced increase in the blood level of tacrolimus in a renal transplant patient. Transplantation. 2003; 75 (7): 1057.
26. Egashira K, Ohtani H, Itoh S, et al. Inhibitory effects of pomelo on the metabolism of tacrolimus and the activities of CYP3A4 and P-glycoprotein. Drug Metab Dispos. 2004; 32 (8): 828-833.
27. Hou YC, Hsiu SL, Tsao CW, Wang YH, Chao PD,. Acute intoxication of cyclosporin caused by coadministration of decoctions of the fruits of Citrus aurantium and the Pericarps of Citrus grandis. Planta Med. 2000; 66 (7): 653-655.
28. Lin SP, Chao PD, Tsai SY, Wang MJ, Hou YC,. Citrus grandis peel increases the bioavailability of cyclosporine and tacrolimus, two important immunosuppressants, in rats. J Med Food. 2011; 14 (11): 1463-1468.
29. Xu J, Go ML, Lim LY,. Modulation of digoxin transport across Caco-2 cell monolayers by citrus fruit juices: lime, lemon, grapefruit, and pummelo. Pharm Res. 2003; 20 (2): 169-176.
30. Grenier J, Fradette C, Morelli G, Merritt GJ, Vranderick M, Ducharme MP,. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther. 2006; 79 (3): 255-262.
31. Zhang Y, Huo M, Zhou J, Xie S,. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 2010; 99 (3): 306-314.
32. (EMEA) EMA. CHMP guideline on the investigation of bioequivalence. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500002963.pdf.
33. Julious SA,. Sample sizes for clinical trials with normal data. Stat Med. 2004; 23 (12): 1921-1986.
34. Guo LQ, Chen QY, Wang X, et al. Different roles of pummelo furanocoumarin and cytochrome P450 3A5∗3 polymorphism in the fate and action of felodipine. Curr Drug Metab. 2007; 8 (6): 623-630.
35. Kongkachuichai R, Charoensiri R, Sungpuag P,. Carotenoid, flavonoid profiles and dietary fiber contents of fruits commonly consumed in Thailand. Int J Food Sci Nutr. 2010; 61 (5): 536-548.
36. Sousa RL, Marletta MA,. Inhibition of cytochrome P-450 activity in rat liver microsomes by the naturally occurring flavonoid, quercetin. Arch Biochem Biophys. 1985; 240 (1): 345-357.
37. Guengerich FP, Kim DH,. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 1990; 11 (12): 2275-2279.
38. Bailey DG, Arnold JM, Strong HA, Munoz C, Spence JD,. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther. 1993; 54 (6): 589-594.
39. Rashid J, McKinstry C, Renwick AG, Dirnhuber M, Waller DG, George CF,. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol. 1993; 36 (5): 460-463.
40. Egashira K, Sasaki H, Higuchi S, Ieiri I,. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats. Drug Metab Pharmacokinet. 2012; 27 (2): 242-247.